Purchase Order W81K0023P0085
- Not listed
- Sysmex America, Inc. was awarded a delivery order valued at $118,697.97 by the Defense Health Agency's Medical Command for hematology analyzer reagents, supplies, and service support. The contract, issued on October 1, 2022, with an ultimate completion date of September 30, 2027, will be performed at Fort Buchanan in Guaynabo, Puerto Rico, and utilizes a firm fixed-price pricing structure with no set-aside designation. This delivery order is issued under the General Services Administration's...
- The Defense Health Agency awarded a $621,311.40 delivery order to Sysmex America, Inc. for the procurement of a Sysmex XN-3100 fully automated hematology analyzer system. This firm fixed-price contract, effective October 1, 2025, with an ultimate completion date of September 30, 2030, will be performed at a location in Prairie View, Illinois. The award was not designated as a small business set-aside. This delivery order is issued under Sysmex America's General Services Administration Multiple...
- Sysmex America, Inc., a U.S. subsidiary of the Japanese medical diagnostics firm Sysmex Corporation, was awarded a $149,547.60 firm fixed price purchase order by the Defense Health Agency on April 14, 2025, for the procurement of a blood count analyzer system and associated reagents. The contract, which carries an ultimate completion date of September 30, 2029, will deliver equipment and services to Fort Stewart, Georgia, specifically supporting the Tuttle Army Health Clinic's Laboratory...
- The Defense Health Agency awarded a delivery order valued at $249,087.24 to Sysmex America, Inc. on April 23, 2025, for cost-per-reportable-result hematology testing services utilizing the XN1000 analyzer with a standalone slide reviewer for complete blood count and peripheral blood smear analysis. This firm fixed price delivery order is set to be completed by September 30, 2026, and will be performed at a location in Prairie View, Illinois. The award represents a continuation of services...
- Sysmex America, Inc., a U.S. subsidiary of Japanese medical diagnostics manufacturer Sysmex Corporation, has been awarded a $120,000 firm fixed-price purchase order by the Defense Health Agency for the procurement of one Sysmex XN1000BB Automated Hematology Analyzer with Blood Bank Mode. The contract, awarded on September 10, 2025, is designated for delivery and installation at Tripler Army Medical Center in Hawaii, with a completion deadline of March 1, 2026. This procurement was conducted as a...
- The Defense Health Agency awarded a $196,693.80 firm fixed price purchase order to Sysmex America, Inc. for a CPR XN-1000 hematology analyzer and associated reagents on September 30, 2021. The contract covers a one-year base period from September 30, 2021 through September 29, 2022, with four option years extending through September 29, 2026, and an additional six-month extension option through March 31, 2027. The equipment and supplies will be delivered to Sheppard Air Force Base in Texas. No...
- The Defense Health Agency awarded a $325,354.20 firm fixed price delivery order to Sysmex America, Inc. for hematology analyzers and reagents to be delivered to Quantico, Virginia, with a completion date of September 30, 2026. This contract was awarded on September 30, 2021, with no set-aside designation. Sysmex America, Inc., a U.S. subsidiary of Japan-based Sysmex Corporation, is a leading provider of clinical laboratory diagnostic equipment and solutions to federal healthcare agencies. The...
- On August 1, 2018, the Defense Health Agency awarded a delivery order to Sysmex America, Inc. for XN 1000 R Analyzer and Sysmex Analyzer equipment with a ceiling value of $78,212.52. This firm fixed-price contract, which was not designated as a set-aside, supported the agency's clinical laboratory capabilities and was performed in Prairie View, Illinois. The delivery order falls under the company's General Services Administration Multiple Award Schedule contract for Critical Analyzers and...
- This firm-fixed-price purchase order was awarded by the Defense Health Agency to Sysmex America, Inc. for the provision of an XN9000 hematology analyzer. The $572,948.69 contract has a completion date of September 30, 2023 and does not have a set-aside designation. Sysmex America, Inc. is a U.S. subsidiary of the Japanese clinical laboratory systems manufacturer Sysmex Corporation, and has received numerous previous federal contract awards to supply hematology equipment, reagents, and associated...
- Sysmex America, Inc., a U.S. subsidiary of the Japanese medical diagnostics corporation specializing in clinical laboratory technologies, received a delivery order contract from the Defense Health Agency valued at $774,056.01 for reagents and controls. Awarded on October 1, 2020, with a completion date of September 30, 2025, this firm fixed-price contract will be performed at Fort Cavazos, Texas. The contract does not utilize a set-aside designation and represents a continuation of Sysmex...
The Defense Health Agency awarded a firm fixed price purchase order to Sysmex America, Inc. for the supply of reagents and a Sysmex XN1000-100 blood parameter analyzer hematology system to be installed and operated at Fort Huachuca in Sierra Vista, Arizona. This contract award represents the exercise of option three under a base plus four-option contract structure, with a ceiling value of $128,425.81 and an ultimate completion date of September 30, 2027. The contract was awarded on April 1, 2023, with no small business set-aside designation applied. Sysmex America, Inc., a U.S. subsidiary of the Japanese medical diagnostics corporation Sysmex Corporation headquartered in Lincolnshire, Illinois, specializes in clinical laboratory diagnostic equipment and related services. This award reflects the Defense Health Agency's ongoing procurement needs for advanced hematology analysis capabilities at military medical facilities. Sysmex America, Inc. maintains an extensive portfolio of federal contracts across multiple healthcare agencies, including numerous multi-year agreements and indefinite delivery vehicles such as a $29.9 million General Services Administration Multiple Award Schedule contract. The company's federal business focuses predominantly on delivering hematology and urinalysis systems, reagents, and comprehensive maintenance support services to the Department of Veterans Affairs, Defense Health Agency, Indian Health Service, and National Institutes of Health, demonstrating established capability in supplying medical diagnostic equipment to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Exercise an Option | $0 | 8/22/25 | |
| P00004 | Funding Only Action | $28.8k | 11/20/24 | |
| P00003 | Exercise an Option | $0 | 4/10/24 | |
| P00002 | Funding Only Action | $31.7k | 1/3/24 | |
| P00001 | Exercise an Option | $0 | 8/21/23 |